Lacia, Baby Boy S.

HRN: 21-74-43  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
AMPICILLIN 250MG (VIAL)
08/03/2022
08/09/2022
IVT
80
Q12
Sepsis
Waiting Final Action 
08/03/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
08/03/2022
08/09/2022
IVT
8mg
Q24
Sepsis
Waiting Final Action 
08/13/2022
CEFTAZIDIME 1GM (VIAL)
08/13/2022
08/19/2022
IVTT
75mg
Q12 X 7 Days
Sepsis
Waiting Final Action 
08/13/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/13/2022
08/19/2022
IVTT
97mg
Od X 7 Days
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: